vascular dementia
vascular dementia
Explore linked clinical trials. Standard reference: MONDO:000464858 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up. | Arterial Occlusive Diseases, Embolism and Thrombosis, Hemorrhage, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Leukoencephalopathies, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, arteriosclerosis disorder, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral infarction, cerebrovascular disorder, cognitive disorder, dementia, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, intracranial thrombosis, ischemic disease, multi-infarct dementia, nervous system disorder, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT07771335 | |
| Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, stroke disorder, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT04337255 | |
| Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers | Alzheimer disease, Arterial Occlusive Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Creutzfeldt Jacob disease, Disease Attributes, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Infections, Leukoencephalopathies, Lewy body dementia, Mixed Dementias, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, prion disease, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-21 | NCT05596760 | |
| Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment | Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Leukoencephalopathies, Mild Cognitive Impairment, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, psychiatric disorder, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-18 | NCT07149038 | |
| Pulsed Electromagnetic Field Treatment With Dementia Patients | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, Lewy body dementia, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-17 | NCT06862557 | |
| The BRAIN App (Phase 2 SBIR) | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-15 | NCT06298474 | |
| Making Connections Thru Music | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-15 | NCT06079216 | |
| Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY | Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Hemorrhage, Intracranial Hemorrhages, Leukoencephalopathies, Mild Cognitive Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, ischemic stroke, nervous system disorder, psychiatric disorder, stroke disorder, subarachnoid hemorrhage, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-09-14 | NCT04916210 | |
| Florida Cerebrovascular Disease Biorepository and Genomics Center | Arterial Occlusive Diseases, Cardiovascular Abnormalities, Cerebral Small Vessel Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism and Thrombosis, Fistula, Hemorrhage, Hypoxia, Hypoxia, Brain, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Leukoaraiosis, Leukoencephalopathies, Moyamoya disease, Necrosis, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Subarachnoid Hemorrhage, Aneurysmal, Thromboembolism, Vascular Fistula, arteriosclerosis disorder, arteriovenous hemangioma/malformation, brain disorder, brain hypoxia - ischemia, brain infarction, brain ischemia, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, congenital arteriovenous fistula, dementia, fibromuscular dysplasia, hereditary disease, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, intracranial thrombosis, ischemic disease, ischemic stroke, nervous system disorder, psychiatric disorder, reversible cerebral vasoconstriction syndrome, stroke disorder, subarachnoid hemorrhage, transient ischemic attack, vascular dementia, vascular disorder, vascular malformation | Active, not recruiting | Not stated | 2026-09-03 | NCT05491980 | |
| Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI) | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, disease, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Not yet recruiting | Not stated | 2026-09-02 | NCT07200739 | |
| Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy. | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Amyloid Angiopathy, Familial, Cerebral Small Vessel Diseases, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, amyloidosis, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, dementia, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, intracranial arterial disease, ischemic disease, metabolic disease, nervous system disorder, proteostasis deficiencies, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-09-01 | NCT06933212 | |
| Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, disease, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-08-31 | NCT06938100 | |
| ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing | Alzheimer disease, Apnea, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Dyssomnias, Leukoencephalopathies, Lewy body dementia, Mild Cognitive Impairment, Mixed Dementias, Respiration Disorders, Sleep Disorders, Intrinsic, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, obstructive sleep apnea syndrome, parkinsonian disorder, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-08-20 | NCT04335994 | |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Leukoencephalopathies, Lewy body dementia, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, arteriosclerosis disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, motor neuron disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not stated | 2026-08-10 | NCT06209515 | |
| Retina is a Marker for Cerebrovascular Heath | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT04753970 | |
| Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-07-23 | NCT07721701 | |
| Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Not yet recruiting | Phase 2 | 2026-07-09 | NCT07692399 | |
| Neurologic Stem Cell Treatment Study | Alzheimer disease, Brain Damage, Chronic, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Cerebral Small Vessel Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Diabetes Complications, Disease Attributes, Frontotemporal Lobar Degeneration, Hemorrhage, Infarction, Intracranial Hemorrhages, Lewy Body Variant of Alzheimer Disease, Lewy body dementia, Necrosis, Nerve Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, basal ganglia disorder, brain disorder, brain infarction, brain injury, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, cranial nerve neuropathy, dementia, dementia pugilistica, demyelinating disease, diabetes mellitus, diabetic neuropathy, endocrine system disorder, eye disorder, frontotemporal dementia, hereditary disease, hypotensive disorder, immune system disorder, injury, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, multiple system atrophy, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, peripheral nervous system disorder, peripheral neuropathy, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, stroke disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-06-26 | NCT02795052 | |
| Imaging of Brain Amyloid Plaques in the Aging Population | Alzheimer disease, Arterial Occlusive Diseases, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Enrolling by invitation | Phase 4 | 2026-06-23 | NCT00950430 | |
| Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2 | Cardiovascular Abnormalities, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Cerebral Small Vessel Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infarction, Necrosis, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, cerebral arterial disease, cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1, cerebral infarction, cerebrovascular disorder, dementia, hemangioma, hematologic disorder, hemorrhagic disease, hereditary disease, intracranial arterial disease, ischemic disease, neoplasm, nervous system disorder, stroke disorder, vascular cancer, vascular dementia, vascular disorder, vascular hemostatic disease, vascular malformation | Not yet recruiting | Not applicable | 2026-06-16 | NCT07650110 | |
| Long-term Prospective Study of Korean CADASIL Patients | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Leukoencephalopathies, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-05-14 | NCT07497867 | |
| Retinal Hyperspectral Imaging in Neurodegenerative Diseases | Alzheimer disease, Arterial Occlusive Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Frontotemporal Lobar Degeneration, Hemic and Lymphatic Diseases, Leukoencephalopathies, Lewy body dementia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Niemann-Pick disease, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, hereditary disease, histiocytosis, inborn errors of metabolism, intracranial arterial disease, intracranial arteriosclerosis, lymphatic system disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, non-Langerhans cell histiocytosis, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, sphingolipidosis, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-04-22 | NCT07545473 | |
| The Swedish BioFINDER - Memory Clinic Study | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Leukoencephalopathies, Lewy body dementia, Mild Cognitive Impairment, Schnyder corneal dystrophy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-04-06 | NCT06122415 | |
| The Swedish BioFINDER - Primary Care Study | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Leukoencephalopathies, Lewy body dementia, Mild Cognitive Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Schnyder corneal dystrophy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, disease, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-04-06 | NCT06120361 | |
| Rifaximin SSD in Dementia Trial | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-03 | NCT06718686 |